article thumbnail

7 Interesting Reasons to Invest In Platinum Today

Strategy Driven

One such example is that of a large Swiss-based pharmaceutical company that invested around $11.3 Liquidity, in business, refers to the ability of an asset like stocks and bonds to be turned into cash with ease. billion in platinum and other metals as well.

Price 67
article thumbnail

Building Partnerships

Marshall Goldsmith

Traditional “bonds” between employees and organizations have changed. The same trend is occurring in pharmaceuticals and telecommunications. The ideal leader is a person who builds internal and external partnerships. Internal partnerships include direct reports, co-workers and managers. Partnering with direct reports.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why CEOs Should Push Back Against Short-Termism

Harvard Business Review

The pharmaceutical company Valeant raised the price of Cuprimine — invented in 1956 and used to treat Wilson’s disease, a rare condition in which the body cannot process copper — from about $500 to about $24,000 for a 30-day supply, causing outrage from consumers.

CEO 8
article thumbnail

Getting Your Career Back on Track After a Catastrophic Error

Harvard Business Review

” Mr. Milken had built a junk-bond empire that brought him more than $1 billion from 1983 to 1987. A client we worked with, a senior pharmaceutical VP, was accused of violating U.S. A year after his sabbatical, our client resumed his career as a consultant to the pharmaceutical industry. Rebecca Knight. Monique Valcour.

Career 8
article thumbnail

How Digital Health Care Can Help Prevent Chronic Diseases Like Diabetes

Harvard Business Review

Some of the San Francisco-based groups, for example, bonded via discussions about the Golden State Warriors basketball team and opportunities to be more active in the city. This group dynamic cultivates a social network that offers real-time feedback, support, and accountability.

article thumbnail

Health Systems Need to Completely Reassess How They Manage Costs

Harvard Business Review

More recently, it has come in the form of the swarms of “apps” sold to individual departments to solve scheduling and care-coordination problems and to “bond” with “consumers.” Fixing this problem is politically challenging because it involves reducing physician numbers, physician incomes, or both.

Cost 10
article thumbnail

What to Know Before You Sign a Payment-by-Results Contract

Harvard Business Review

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. As a result, some governments and private foundations have introduced social impact bonds to provide the necessary working capital. ” Health care. Making PbR Work.